Volume 12, Issue 1 , Pages 40-43, January 2010
Argon plasma coagulation for Barrett's esophagus
Barrett's esophagus is a metaplastic complication of gastroesophageal reflux disease that predisposes to the development of adenocarcinoma of the esophagus. Treatment of the condition centers on acid suppression and prevention of progression to high-grade dysplasia or adenocarcinoma. Endoscopic ablation of the Barrett's mucosa, with reversion of intestinal metaplasia to squamous epithelium, may achieve the latter aim and can be performed using various modalities. There are many ablation options to eradicate the Barrett's mucosa. This review will focus on a review of the published data reporting ablation of Barrett's mucosa using argon plasma coagulation. This use of argon plasma coagulation for the ablation of Barrett's mucosa has previously been reviewed by Franchimont et al (Gastrointest Endosc Clin N Am 13:457-466, 2003) and Nomura et al (Nippon Rinsho 63:1458-1462, 2005).
Keywords: Barrett's esophagus, Intestinal metaplasia, Argon plasma coagulation, Mucosal ablation
To access this article, please choose from the options below
The authors report no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.
PII: S1096-2883(10)00004-5
doi:10.1016/j.tgie.2010.01.003
Crown Copyright © 2010. Published by Elsevier Inc. All rights reserved.
Volume 12, Issue 1 , Pages 40-43, January 2010
